Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-15

FDA Approved: SOLOSEC — Supplemental Application (Evofem Inc.)

View source ↗

Summary

FDA approved a supplemental application for SOLOSEC (secnidazole) submitted by Evofem Inc. The action represents an approved supplemental submission for the pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SOLOSEC (secnidazole)

Snippet

SUPPL AP for SOLOSEC (SECNIDAZOLE)